Category: Gaucher's
Gaucher's market research reports by GlobalData
-
Gaucher Disease - Global Clinical Trials Review, 2024
Gaucher Disease - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Gaucher Disease - Global Clinical Trials Review, 2024" provides an overview of Gaucher Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher ... Read More
-
Gaucher Disease - Opportunity Assessment and Forecast
Gaucher Disease - Opportunity Assessment and Forecast Summary The prevalence of GD is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 0.39%. Currently, the marketed treatment regimen for Type 1 GD and Type 3 GD is dominated by ERTs and SRTs (Cerezyme, VPRIV, Elel ... Read More
-
Gaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gaucher Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Gaucher Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Up ... Read More
Research Assistance
